Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3Thoracic 1Dermatologic 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 133Lung Neoplasms 74Brain Neoplasms 27Small Cell Lung Carcinoma 15Melanoma 13Breast Neoplasms 12Neoplasm Metastasis 11Neoplasms 9Carcinoma, Renal Cell 7Adenocarcinoma of Lung 7Prostatic Neoplasms 6NSCLC 5Urinary Bladder Neoplasms 4Recurrence 3Liver Neoplasms 3Kidney Neoplasms 3Gastrointestinal Neoplasms 3Carcinoma, Bronchogenic 3Bronchial Neoplasms 3Breast Neoplasms, Male 3Thoracic Neoplasms 2Sarcoma 2Respiratory Tract Neoplasms 2Respiratory Tract Diseases 2Neoplasms by Site 2Mesothelioma 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Carcinoma, Squamous Cell 2Carcinoma, Neuroendocrine 2

Interventions

Specimen Handling 2Nivolumab 2atezolizumab 1Tissue Banks 1Radiosurgery 1Magnetic Resonance Spectroscopy 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Clear-cell metastatic renal cell carcinoma × Radiosurgery × Thoracic × Clear all
NCT02978404 2024-06-28

Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases

Centre hospitalier de l'Université de Montréal (CHUM)

Phase 2 Completed
26 enrolled
CNSDermatologicGenitourinaryThoracic

Clear-cell metastatic renal cell carcinoma, Brain Neoplasms, Melanoma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡